Display options
Share it on

Female Pelvic Med Reconstr Surg. 2010 May;16(3):188-95. doi: 10.1097/SPV.0b013e3181d7e86e.

Systemic effects of vaginally administered estrogen therapy: a review.

Female pelvic medicine & reconstructive surgery

Megan Krause, Thomas L Wheeler, Holly E Richter, Thomas E Snyder

Affiliations

  1. From the *Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS; †Department of Obstetrics and Gynecology, University of South Carolina, University Greenville Campus, Greenville, SC; and ‡Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.

PMID: 22453284 PMCID: PMC4354766 DOI: 10.1097/SPV.0b013e3181d7e86e

Abstract

Hormone therapy was considered the standard of care before the publication of the Women's Health Initiative. After the study was published, the use of systemic hormone therapy dramatically decreased resulting in an increased incidence of menopausal symptoms such as hot flashes, vaginal dryness, and dyspareunia experienced by women. Use of vaginal estrogen offers women a unique alternative for relief of these symptoms. This article reviews the systemic effects of vaginally administered estrogen. Effects on serum hormone levels, vasomotor symptoms, lipid profiles, and use in women with breast cancer are reviewed. An accompanying review (J Pelvic Med Surg. 2009;15:105-114.) examines the local effects of vaginally administered estrogen.

References

  1. Am J Obstet Gynecol. 1997 Jul;177(1):115-9 - PubMed
  2. N Engl J Med. 1991 Sep 12;325(11):756-62 - PubMed
  3. N Engl J Med. 2000 Aug 24;343(8):522-9 - PubMed
  4. Contraception. 1995 Jan;51(1):39-44 - PubMed
  5. JAMA. 2002 Jul 17;288(3):321-33 - PubMed
  6. JAMA. 2003 May 28;289(20):2673-84 - PubMed
  7. Maturitas. 1990 Sep;12(3):259-85 - PubMed
  8. Semin Reprod Med. 2005 May;23(2):126-40 - PubMed
  9. Obstet Gynecol. 1984 Apr;63(4):441-4 - PubMed
  10. Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1480-3 - PubMed
  11. Ann Intern Med. 1992 Dec 15;117(12):1016-37 - PubMed
  12. J Clin Endocrinol Metab. 1975 Mar;40(3):518-21 - PubMed
  13. Prev Med. 1991 Jan;20(1):47-63 - PubMed
  14. J Womens Health (Larchmt). 2002 Dec;11(10):857-77 - PubMed
  15. JAMA. 2003 Oct 1;290(13):1739-48 - PubMed
  16. Arteriosclerosis. 1990 Nov-Dec;10(6):1051-7 - PubMed
  17. N Engl J Med. 1980 Nov 20;303(21):1195-8 - PubMed
  18. JAMA. 2003 Oct 1;290(13):1729-38 - PubMed
  19. JAMA. 1998 Aug 19;280(7):605-13 - PubMed
  20. N Engl J Med. 2003 Aug 7;349(6):523-34 - PubMed
  21. Eur J Cancer. 2005 Nov;41(17):2673-81 - PubMed
  22. Obstet Gynecol. 2003 Oct;102(4):823-34 - PubMed
  23. N Engl J Med. 1998 Sep 10;339(11):733-8 - PubMed
  24. Cochrane Database Syst Rev. 2003;(4):CD001500 - PubMed
  25. JAMA. 2003 Jun 25;289(24):3243-53 - PubMed
  26. Maturitas. 1993 Sep;17(2):129-37 - PubMed
  27. JAMA. 1995 Jan 18;273(3):199-208 - PubMed
  28. J Clin Endocrinol Metab. 1983 Jul;57(1):133-9 - PubMed
  29. Maturitas. 1991 Jun;13(2):99-107 - PubMed
  30. Ann Oncol. 2006 Apr;17(4):584-7 - PubMed
  31. N Engl J Med. 1978 Jan 26;298(4):195-7 - PubMed
  32. Cancer Causes Control. 1992 Jul;3(4):355-60 - PubMed
  33. N Engl J Med. 2006 Nov 30;355(22):2338-47 - PubMed
  34. J Clin Endocrinol Metab. 2001 Jun;86(6):2757-62 - PubMed

Publication Types

Grant support